| N-formylmethionyl-leucyl-phenylalanine carboxypeptidase | <enzyme> Human salivary enzyme liberates phenylalanine from the chemotactic peptide n-formylmethionine leucyl-phenylalanine Registry number: EC 3.4.- Synonym: n-formyl-methionine leucyl-phenylalanyl carboxypeptidase, formylmet-leu-phe carboxypeptidase (26 Jun 1999) |
|---|---|
| DD-carboxypeptidase-endopeptidase | <enzyme> Hydrolyzes c-terminal d-ala-d-peptide, where second amino acid can vary Registry number: EC 3.4.15.- Synonym: dacf protein (26 Jun 1999) |
| dipeptidyl carboxypeptidase | <enzyme> Hydrolytically removes dipeptides from the carboxyl end of low- and high-mol wt peptides Registry number: EC 3.4.15.- Synonym: dipeptidocarboxypeptidase, peptidyl-dipeptidase dcp (26 Jun 1999) |
| Thermus aquaticus carboxypeptidase | <enzyme> A zinc-dependent metallo-carboxypeptidase; has 511 amino acid residues; mw 56,210 da; genbank d17669 Registry number: EC 3.4.- Synonym: carboxypeptidase taq, taq carboxypeptidase, cpase taq (26 Jun 1999) |
| urinary carboxypeptidase | <enzyme> From human urine; can be distinguished from kininase I, kininase II and enkephalin convertase Registry number: EC 3.4.17.- Synonym: kininase one-an'-a-half (26 Jun 1999) |
| lysine carboxypeptidase | <enzyme> A serine carboxypeptidase that removes c-terminal amino acids, preferentially lysine, from peptides and proteins. It inactivates bradykinin by this action. Registry number: EC 3.4.17.3 (12 Dec 1998) |
| amorphous insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| butter of zinc | ZnCl2;formerly used as a caustic for the removal of cutaneous cancers, nevi, etc., and in weak solution in the treatment of gonorrhoea and conjunctivitis. Synonym: butter of zinc. (05 Mar 2000) |
| globin zinc insulin | A sterile solution of insulin modified by the addition of zinc chloride and globin; it contains 40 or 80 units per ml; duration of action is about 18 hours. Human insulin, a protein that has the normal structure of insulin produced by the human pancreas, prepared by recombinant DNA techniques and by semisynthetic processes. Immunoreactive insulin (IRI), that portion of insulin in blood measured by immunochemical methods for the hormone; presumed to represent the free (unbound) and biologically active fraction of total blood insulin. Isophane insulin, a modified form of insulin composed of insulin, protamine, and zinc; an intermediately acting preparation used for the treatment of diabetes mellitus. Synonym: NPH insulin. (05 Mar 2000) |
| medicinal zinc peroxide | A mixture of zinc peroxide, zinc carbonate, and zinc hydroxide; a topical disinfectant, astringent, and deodorant. (05 Mar 2000) |
| modified zinc oxide-eugenol cement | Dental cement obtained by mixing zinc oxide and eugenol with one or more additives. (05 Mar 2000) |
| crystalline insulin zinc suspension | A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours. Synonym: crystalline insulin zinc suspension. (05 Mar 2000) |
| prompt insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| protamine zinc insulin | Insulin modified by the addition of protamine and zinc chloride; it contains 40 or 80 units per ml. (05 Mar 2000) |
| deficiency dermatitis and diarrhoea, zinc | A genetic disease called acrodermatitis enteropathica is characterised by the simultaneous occurrence of skin inflammation (dermatitis) and diarrhoea. The skin on the cheeks, elbows and knees and tissue about the mouth and anus are inflammed. There is also balding of the scalp, eyebrows and lashes, delayed wound healing and recurrent bacterial and fungal infections due to immune deficiency. The key laboratory finding is an abnormally low blood zinc level reflecting impaired zinc uptake. Oral treatment with zinc is curative. (12 Dec 1998) |